SMARCA4 Gene Mutation: Clinical Trials

1 trial for SMARCA4 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow SMARCA4 Gene Mutation: new trials by email Literature Review of SMARCA4 Gene Mutation trials Research Report on SMARCA4 Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
PRT3789, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1CompletedPrelude Therapeutics Incorporated1352023-05-022025-10-16

Narrower conditions

Neoplasm Metastasis (1)

Broader conditions

Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Docetaxel (1)

Sponsors

Prelude Therapeutics Incorporated (1)

Countries

France (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)  ·  United States (1)